Affiliation:
1. 1 Departments of Endocrinology
2. 2 Pathology, University Hospital Complex, Albacete, Spain
3. 3 OCDEM, Churchill Hospital, Oxford, UK
Abstract
Summary
Neuroendocrine tumours (NETs) are a heterogeneous group of neoplasms whose management can be problematic. In many cases, multiple tumours may occur in the same patient or his or her family, and some of these have now been defined genetically, although in other cases the underlying gene or genes involved remain unclear. We describe a patient, a 63-year-old female, who was diagnosed with a medullary thyroid carcinoma (MTC), which was confirmed pathologically after thyroidectomy, but whose circulating calcitonin levels remained elevated after thyroidectomy with no evidence of metastatic disease. Subsequently, an entirely separate and discrete duodenal NET was identified; this was 2.8 cm in diameter and was removed at partial duodenectomy. The tumour stained immunohistochemically for calcitonin, and its removal led to persistent normalisation of the circulating calcitonin levels. There was no germline mutation of the RET oncogene. This is the first identification of a duodenal NET secreting calcitonin and also the first demonstration of a second tumour secreting calcitonin in a patient with MTC. We suggest that where calcitonin levels remain high after removal of a MTC a search for other NETs should be conducted.
Learning points
NETs are a complex and heterogeneous group of related neoplasms, and multiple tumours may occur in the same patient.
Calcitonin can be produced ectopically by several tumours outside the thyroid.
Persistently elevated calcitonin levels after removal of a MTC may not necessarily indicate persisting or metastatic disease from the tumour.
The real prevalence of calcitonin-producing NETs may be underestimated, as serum determination is only recommended in the diagnosis of pancreatic NETs.
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference22 articles.
1. Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival;Annals of Surgery
2. Consensus guidelines for the management of patients with digestive neuroendocrine tumors well-differentiated jejunal-ileal tumor/carcinoma;Neuroendocrinology,2008
3. Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography;Quarterly Journal of Nuclear Medicine and Molecular Imaging,2010
4. of and Spanish of Spanish group of neuroendocrine tumors Practical guide for the diagnosis treatment and monitoring of neuroendocrine tumors;Spanish;Society Endocrinology Nutrition Society Medical Oncology,2010
5. Consensus guidelines for the management of patients with digestive neuroendocrine tumors well-differentiated jejunal-ileal tumor/carcinoma;Neuroendocrinology,2008
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献